S 5022: Cannabis Administration and Opportunity Act

S 5022 in plain English: This bill would remove cannabis from the federal Controlled Substances Act, creating a federal regulatory and taxation framework for cannabis. It establishes programs to address the harms of past cannabis enforcement, including expungement of prior convictions and funding for communities disproportionately affected. Legal cannabis sales totaled $33,600,000,000 in 2023 and are projected to reach $56,900,000,000 by 2028.

Stated purpose

This bill aims to remove cannabis from the federal controlled substances list, expunge certain past cannabis-related criminal records, and direct funding toward communities and individuals harmed by past drug enforcement policies.

Key points

• Removes cannabis from federal controlled substances law and establishes a federal system to regulate and tax it
• Allocates $1,650,000,000 for fiscal year 2026 and $275,000,000 annually through 2030 for community reinvestment programs
• Provides $200,000,000 per year for fiscal years 2026–2030 for small business and related cannabis equity programs
• Increases drug treatment and prevention funding to $596,000,000 per year for fiscal years 2026–2030
• Enforcing cannabis prohibition currently costs taxpayers approximately $3,600,000,000 per year, according to the ACLU

Arguments supporters make

• Keeping cannabis federally illegal while most states have legalized it creates confusion and unfairly burdens people and businesses; federal law should reflect reality.
• People—disproportionately from minority communities—who served time for cannabis offenses that are now legal or tolerated in many states deserve a chance to clear their records and move forward.
• Taxing and regulating cannabis at the federal level generates revenue that can fund public health, research, and reinvestment in communities most hurt by past enforcement.

Arguments opponents make

• Federally descheduling cannabis could make it easier for young people to access the drug and may undermine public health, especially before research on long-term harms is complete.
• States that have chosen to keep cannabis illegal could face pressure or spillover effects from federal legalization, reducing their ability to set their own drug policies.
• A large new federal regulatory structure with trust funds, grants, and multiple agencies could be costly and difficult to administer, with no guarantee the money reaches those most in need.

Tradeoffs

Removing federal cannabis restrictions would expand personal freedom and business opportunity, but may increase public health risks or youth access that existing research has not yet fully measured. Directing tax revenue toward harmed communities addresses past inequities, but creates new federal spending commitments whose effectiveness is uncertain.

Current status in Congress: In committee.

NewsClear — neutral news & congressional tracking · Bill of the Week